It's a package deal - what big pharma dream of and working towards.
One stop shop.
To be able to diagnose patients conditions & then be able to put them straight onto their drugs.
Significantly increase the attractiveness to acquisition & Phylogica is in the guts of it on both fronts.
They just need to nail it - has to be getting close
Anticipating Genetechs update in coming days/weeks.
European patent, page-2
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $676.5M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.5¢ | 13.5¢ | $687.7K | 4.887M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 87494 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 2187900 | 13 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| PYC (ASX) Chart |